Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | 2.40% | 70.55 | 5.6% | $182.80m | |
| CTLT | Catalent, Inc. | 2.88% | 97.38 | 2.1% | $122.62m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 1.93% | 19.54 | 14.1% | $114.98m | |
| BHC | Bausch Health Cos., Inc. | 1.93% | 19.54 | 0.0% | $82.27m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.02% | 143.28 | 2.4% | $79.60m | |
| GWPH | GW Pharmaceuticals Plc | 1.65% | 129.71 | 6.1% | $68.89m | |
| PRGO | Perrigo Co. Plc | 0.21% | 48.03 | 6.8% | $56.45m | |
| UTHR | United Therapeutics Corp. | 0.35% | 135.54 | 14.1% | $55.32m | |
| SAGE | SAGE Therapeutics, Inc. | -8.62% | 75.57 | 8.6% | $53.25m | |
| ARGX | argenx SE | 6.07% | 281.59 | 0.0% | $40.59m | |
| SAVA | Cassava Sciences, Inc. | 0.78% | 7.76 | 0.0% | $38.85m | |
| ICLR | ICON plc | 1.54% | 191.14 | 4.2% | $36.74m | |
| AMRN | Amarin Corp. Plc | 0.00% | 4.60 | 1.5% | $36.00m | |
| BLRX | BioLineRx Ltd. | 3.11% | 2.32 | 1.8% | $35.68m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -0.32% | 37.27 | 16.8% | $32.30m |
Company Profile
Zogenix, Inc. is a pharmaceutical company. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.